| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |